Molecules + medicines

Research in this area will advance the diagnosis, treatment and prevention of human disease through understanding of disease mechanisms at the cellular and molecular level; sophisticated, personalized diagnostic tests to determine causes and therapy; and new medical interventions and preventative measures using drugs, biologics and devices.

Select KU research in this area

A group of Clara Biotech staff stands on stage holding two large checks

Biotech company with KU roots wins national competition, secures funding

Clara Biotech refined a novel technology to isolate and purify exosomes, which can be used for early disease diagnosis, targeted drug delivery, cancer immunotherapy and more.
A graphic of a coronavirus, with a photo of Scott Lovell on the right

KU researcher part of teams developing treatments for COVID-19, other infectious diseases

Scott Lovell, director of KU’s Protein Structure & X-Ray Crystallography Lab, and three collaborators received a $3.7 million grant to develop an antiviral therapeutic treatment that could help people who have contracted SARS-CoV-2.
A researcher works in the CBID lab

With new $11.35M NIH COBRE award, KU center continues fight against infectious diseases

The National Institutes of Health has re-upped its support of the Chemical Biology of Infectious Disease Center (CBID) at the University of Kansas with a five-year, $11.35 million grant.
Steven Soper and two researchers tour lab where COVID-19 test is made

At home COVID-19 test developed at KU moves toward production

University of Kansas researchers, led by Steven Soper, have created an at-home rapid COVID-19 test using "lab on a chip" technology. They aim to launch the product in early 2022.